Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of … (NCT06296953) | Clinical Trial Compass
CompletedNot Applicable
Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis
Sweden40 participantsStarted 2024-03-15
Plain-language summary
This will be an explorative, proof-of-principle, open, multi-center investigation.
The investigation aims to investigate the safety of the PERIsign system and the ability of physicians to differentiate between healthy individuals and subjects with involuntary muscle defense as a sign of peritonitis by utilizing PERIsign data. The investigation will include a total of 20 subjects admitted to hospital for suspected appendicitis and planned for emergency surgery and 20 healthy volunteers. Both male and female subjects aged 18-70 years will be enrolled.
All subjects will undergo PERIsign examinations. Subjects with suspected appendicitis will undergo 1-2 PERIsign examinations before their planned appendectomy surgery. For the healthy volunteers, there is only 1 PERIsign examination. During each examination, 4 PERIsign curves will be obtained, one from each quadrant of the abdomen. The attending physician will interpret the appearance of the PERIsign curves of all subjects, including those from the healthy volunteers. The duration of the PERIsign examination will be documented, and usability data will be gathered, including the need for sensor adjustments, subject perception of the examination, and any discomfort experienced. In addition, blinded physicians will evaluate all subjects' PERIsign curves and determine whether each subject has involuntary muscle defense as a sign of peritonitis. These blinded physicians will have access to all 4 PERIsign curves obtained during each examination, while other data will not be disclosed to them.
Safety will be evaluated through analysis of reported adverse events and device deficiencies
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Subject is 18-70 years of age
✓. The subject reports having understood and has signed the Informed Consent Form (ICF) and is willing to comply with all assessments
✓. The subject should have a sufficient height and physical build to enable the attachment of the PERIsign sensors to their abdomen, as judged by the Investigator Inclusion criteria for the patient group
✓. Patient is 18-70 years of age
✓. The patient reports having understood and has signed the ICF and is willing to comply with all assessments
✓. The patient is admitted to the hospital with suspected appendicitis and scheduled for emergency surgery within 24 hours.
✓. Patient is deemed clinically stable, as judged by the Investigator
✓. The patient should have a sufficient height and physical build to enable the attachment of the PERIsign sensors to their abdomen, as judged by the Investigator
Exclusion criteria
What they're measuring
1
Proportion of subjects experiencing any adverse events during the examination
Timeframe: 1 hour
2
Proportion of device deficiencies during the evaluation